Skip to content
value.today

Pneuma Respiratory, Inc.

🇺🇸 Boone, North Carolina, USAPharmaceuticalsFounded 2015

Formerly Genesis Pulmonary, Inc.

Total raised
$37 M
7 rounds on record
Latest round
$4 M
Jun 2026
First round on record
Mar 2018
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pneuma Respiratory, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2026$4 MNo. 7$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 7, Jun 2026

Investors in this round

19 investors had bought by the notice of Jul 1, 2026: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Common Stock and Warrants to Purchase Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • Douglas E. Stoner · Director
  • Farrukh Eric Hameed · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director
  • John E. Hand · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Eric Hunter, Chief Executive Officer. Newest notice filed Jul 1, 2026. Read the notice at the SEC.

equity, optionsSEC
Feb 2025$3 MNo. 6$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 6, Feb 2025

Investors in this round

14 investors had bought by the notice of Dec 3, 2025: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, other: Convertible Notes and Warrants to Purchase Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • Douglas E. Stoner · Director
  • Farrukh Eric Hameed · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Eric Hunter, Chief Executive Officer. Newest notice filed Dec 3, 2025. Read the notice at the SEC.

debt, optionsSEC
Nov 2024$3 MNo. 5$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 5, Nov 2024

Investors in this round

26 investors had bought by the notice of Dec 3, 2025: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$10,000
What was sold
debt, options or other rights to buy securities, other: Convertible Notes and Warrants to Puchase Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • Douglas E. Stoner · Director
  • Farrukh Eric Hameed · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Eric Hunter, Chief Executive Officer. Newest notice filed Dec 3, 2025. Read the notice at the SEC.

debt, optionsSEC
Jun 2023$7 MNo. 4$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 4, Jun 2023

Investors in this round

68 investors had bought by the notice of Dec 23, 2024: 68 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M (amount offered: indefinite)
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in North Carolina

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • May Eric Shen · Executive Officer · Chief Financial Officer
  • Douglas E. Stoner · Director
  • Farrukh Eric Hameed · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director · Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Eric Hunter, Chief Executive Officer. Newest notice filed Dec 23, 2024. Read the notice at the SEC.

equity, optionsSEC
Jul 2019$7 MNo. 3$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 3, Jul 2019

Investors in this round

36 investors had bought by the notice of Aug 10, 2021: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
$18,360
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in North Carolina

People named in the notice

  • C. Eric Hunter · Executive Officer · Chief Executive Officer
  • Sally Eric Yanchus · Executive Officer · Vice President of Finance
  • Douglas E. Stoner · Director
  • Farnkh Phillip Hameed · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director · Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Eric Hunter, Ceo. Newest notice filed Aug 10, 2021 (2 amendments). Read the notice at the SEC.

equitySEC
Feb 2019$5 MNo. 2$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 2, Feb 2019

Investors in this round

34 investors had bought by the notice of Jul 30, 2019: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$12,503
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in North Carolina

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • Richard A. Gimigliano · Executive Officer · Chief Financial Officer and SVP of Business Development
  • Douglas E. Stoner · Director
  • J. Knox Singleton · Director
  • Jay Phillip Morgan · Director
  • Walter L. Robb · Director · Chairman of the Board
  • Wei E. Zheng · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard A. Gimigliano, Cfo & svp. Newest notice filed Jul 30, 2019 (4 amendments). Read the notice at the SEC.

equitySEC
Mar 2018$8 MNo. 1$2 to $10 million

Pneuma Respiratory, Inc.: Raise no. 1, Mar 2018

Investors in this round

52 investors had bought by the notice of May 31, 2018: 52 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $15 M offered; $7 M still to sell
Smallest investment taken
$10,200
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in North Carolina

People named in the notice

  • C. Eric Hunter · Executive Officer, Director · Chief Executive Officer
  • Jocelyn E. Hunter · Executive Officer · Treasurer and Corporate Secretary
  • Douglas E. Stoner · Director
  • Jay Phillip Morgan · Director
  • Walter E. Robb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This is a best efforts offering. There is no assurance that any additional securities will be sold.”

Signed by C. Eric Hunter, Ceo. Newest notice filed May 31, 2018 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pneuma Respiratory, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2026).

    SEC Form D · Jul 2026

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jul 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pneuma Respiratory, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pneuma Respiratory, Inc.
NameRoleNamed in
C. Eric HunterChief Executive OfficerJul 2026
May Eric ShenChief Financial OfficerDec 2024
Sally Eric YanchusVice President of FinanceAug 2021
Richard A. GimiglianoChief Financial Officer and SVP of Business DevelopmentFeb 2020
Jocelyn E. HunterTreasurer and Corporate SecretaryMay 2018
C. Eric HunterChief Executive OfficerJul 2026
Douglas E. StonerDirectorJul 2026
Farrukh Eric HameedDirectorJul 2026
J. Knox SingletonDirectorJul 2026
Jay Phillip MorganDirectorJul 2026
John E. HandDirectorJul 2026
Farnkh Phillip HameedDirectorAug 2021
Farrukh E. HameedDirectorFeb 2020
Walter L. RobbDirectorFeb 2020
Wei E. ZhengDirectorFeb 2020
Walter E. RobbDirectorMay 2018